PolyPid Ltd

PYPD ·Healthcare, Medical Devices, Israel
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Dec 2021 Jun 2021 Dec 2020 Jun 2020 Dec 2019
Revenue
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $7.4M $4.3M
SG&A Expense $2.4M $2.6M
Operating Income $-10.6M $-7.3M
Operating Margin
Interest Expense
Pretax Income
Income Tax Expense
Net Income $-10.5M $-17.0M
Net Margin
EPS (Basic) $0.56 $25.30
EPS (Diluted) $0.56 $25.30
Shares Outstanding (Basic) 18.8M 18.7M 18.5M 562.7K
Shares Outstanding (Diluted) 18.8M 18.7M 18.5M 755.3K 562.7K
Dividends Per Share
← Newer Page 2 of 2 Older →